Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9DKY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,680
Award facts
- Contract value 100% obligated
- $14,679.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,679.92 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injections on January 16, 2026, with completion scheduled for January 20, 2026. This firm fixed-price, non-set-aside contract is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999.999 billion through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, competes on a full and open basis for federal contracts without set-aside designations. The company's extensive portfolio with the Defense Logistics Agency encompasses a wide spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. Dupixent, a biologic treatment for eczema and other inflammatory conditions, represents the type of specialized pharmaceutical product the company routinely supplies to military treatment facilities and other federal healthcare systems through its established contractual relationships with DLA.
Quick answers
Who was awarded contract SPE2DR26F9DKY?
SPE2DR26F9DKY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F9DKY worth?
The government has obligated $14,680 on SPE2DR26F9DKY.
Is contract SPE2DR26F9DKY an order under another contract?
Yes. SPE2DR26F9DKY is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9DKY competed?
The extent of competition for SPE2DR26F9DKY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award